Role of genetic modifiers in an orthologous rat model of ARPKD

Physiological Genomics

Volumn 44, Issue 15, 2012, Pages 741-753

  O'Meara, Caitlin C ^a   Hoffman, Matthew ^a   Sweeney, William E ^a   Tsaih, Shirng Wern ^a   Xiao, Bing ^a   Jacob, Howard J ^a   Avner, Ellis D ^a   Moreno, Carol ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Genetic modifiers; Polycystic kidney disease

Indexed keywords

CREATININE; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BILE DUCT CYST; CELL PROLIFERATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EXTRACELLULAR MATRIX; FAWN HOODED HYPERTENSIVE RAT; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC SUSCEPTIBILITY; INFLAMMATION; INTROGRESSION; KIDNEY MASS; KIDNEY POLYCYSTIC DISEASE; LIVER WEIGHT; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; UREA NITROGEN BLOOD LEVEL;

ANIMALIA; RATTUS;

EID: 84865616207     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00187.2011     Document Type: Article

References (50)

1. Affymetrix. BRLMM-P: a Genotype Calling Method for the SNP 5.0 Array. In: http://www.affymetrix.com/support/technical/whitepapers.affx. (2007), accessed 03 October 2011.
2. Bergmann C, Senderek J, Sedlacek B, Pegiazoglou I, Puglia P, Eggermann T, Rudnik-Schneborn S, Furu L, Onuchic LF, de Baca M, Germino GG, Guay-Woodford L, Somlo S, Moser M, Büttner R, Zerres K. Spectrum of mutations in the gene for autosomal recessive polycystic kidney disease (ARPKD/PKHD1). J Am Soc Nephrol 14: 76-89, 2003.
3. Bergmann C, Senderek J, Windelen E, Kupper F, Middeldorf I, Schneider F, Dornia C, Rudnik-Schoneborn S, Konrad M, Schmitt CP, Seeman T, Neuhaus TJ, Vester U, Kirfel J, Buttner R, Zerres K. Clinical consequences of PKHD1 mutations in 164 patients with autosomalrecessive polycystic kidney disease (ARPKD). Kidney Int 67: 829-848, 2005.
4. Bihoreau MT, Megel N, Brown JH, Kranzlin B, Crombez L, Tychinskaya Y, Broxholme J, Kratz S, Bergmann V, Hoffman S, Gauguier D, Gretz N. Characterization of a major modifier locus for polycystic kidney disease (Modpkdr1) in the Han:SPRD(cy/) rat in a region conserved with a mouse modifier locus for Alport syndrome. Hum Mol Genet 11: 2165-2173, 2002.
5. Cole BR, Conley SB, Stapleton FB. Polycystic kidney disease in the first year of life. J Pediatr 111: 693-699, 1987.
6. Davis ID, Ho M, Hupertz V, Avner ED. Survival of childhood polycystic kidney disease following renal transplantation: the impact of advanced hepatobiliary disease. Pediatr Transplant 7: 364-369, 2003.
7. de Keijzer MH, Provoost AP, Molenaar JC. Proteinuria is an early marker in the development of progressive renal failure in hypertensive fawn-hooded rats. J Hypertens 7: 525-528, 1989.
8. Dell K, Avner ED. Polycystic kidney disease, autosomal recessive. In: Gene Reviews, edited by Pagon R, Bird T, Dolan C and Stephens K. Seattle, WA: University of Washington, Seattle, 2009.
9. Dell KM, Nemo R, Sweeney WE Jr, Avner ED. EGF-related growth factors in the pathogenesis of murine ARPKD1. Kidney Int 65: 2018-2029, 2004.
10. Fejes-Toth A, Fejes-Toth G. Immunoselection and culture of cortical collecting duct cells. Meth Cell Sci 13: 179-184, 1991.
11. Gattone VH II, Ricker JL, Trambaugh CM, Klein RM. Multiorgan mRNA misexpression in murine autosomal recessive polycystic kidney disease. Kidney Int 62: 1560-1569, 2002.
12. Gattone VH, Maser RL, Tian C, Rosenberg JM, Branden MG. Developmental expression of urine concentration-associated genes and their altered expression in murine infantile-type polycystic kidney disease. Dev Genet 24: 309-318, 1999.
13. Goto M, Hoxha N, Osman R, Dell K. The renin-angiotensin system and hypertension in autosomal recessive polycystic kidney disease. Pediatr Nephrol 25: 2449-2457, 2010.
14. Goto M, Hoxha N, Osman R, Wen J, Wells RG, Dell KM. Reninangiotensin system activation in congenital hepatic fibrosis in the PCK rat model of autosomal recessive polycystic kidney disease. J Pediatr Gastroenterol Nutr 50: 639-644, 2010.
15. Guay-Woodford LM. Molecular insights into the pathogenesis of inherited renal tubular disorders. Curr Opin Nephrol Hypertens 4: 121-129, 1995.
16. Guay-Woodford LM. Murine models of polycystic kidney disease: molecular and therapeutic insights. Am J Physiol Renal Physiol 285: F1034-F1049, 2003.
17. Guay-Woodford LM, Desmond RA. Autosomal recessive polycystic kidney disease: the clinical experience in North America. Pediatrics 111: 1072-1080, 2003.
18. Gunay-Aygun M, Font-Montgomery E, Lukose L, Tuchman M, Graf J, Bryant JC, Kleta R, Garcia A, Edwards H, Piwnica-Worms K, Adams D, Bernardini I, Fischer RE, Krasnewich D, Oden N, Ling A, Quezado Z, Zak C, Daryanani KT, Turkbey B, Choyke P, Guay-Woodford LM, Gahl WA. Correlation of kidney function, volume and imaging findings, and PKHD1 mutations in 73 patients with autosomal recessive polycystic kidney disease. Clin J Am Soc Nephrol 5: 972-984, 2010.
19. Hillman KA, Woolf AS, Johnson TM, Wade A, Unwin RJ, Winyard PJD. The P2X7 ATP receptor modulates renal cyst development in vitro. Biochem Biophys Res Commun 322: 434-439, 2004.
20. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37: 1-13, 2009.
21. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44-57, 2009.
22. Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millan JL, Gamble V, Harris PC. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet 10: 151-160, 1995.
23. Jia G, Kwon M, Liang H, Mortensen J, Nilakantan V, Sweeney W, Park F. Chronic treatment with lisinopril decreases proliferative and apoptotic pathways in autosomal recessive polycystic kidney disease. Pediatr Nephrol 25: 1139-1146, 2010.
24. Katsuyama M, Masuyama T, Komura I, Hibino T, Takahashi H. Characterization of a novel polycystic kidney rat model with accompanying polycystic liver. Exp Anim 49: 51-55, 2000.
25. Kotsis F, Nitschke R, Boehlke C, Bashkurov M, Walz G, Kuehn E. Ciliary calcium signaling is modulated by kidney injury molecule-1 (Kim1). Pflügers Arch 453: 819-829, 2007.
26. Kottgen A, Pattaro C, Boger CA, Fuchsberger C, Olden M, Glazer NL, Parsa A, Gao X, Yang Q, Smith AV, O'Connell JR, Li M, Schmidt H, Tanaka T, Isaacs A, Ketkar S, Hwang SJ, Johnson AD, Dehghan A, Teumer A, Pare G, Atkinson EJ, Zeller T, Lohman K, Cornelis MC, Probst-Hensch NM, Kronenberg F, Tonjes A, Hayward C, Aspelund T, Eiriksdottir G, Launer LJ, Harris TB, Rampersaud E, Mitchell BD, Arking DE, Boerwinkle E, Struchalin M, Cavalieri M, Singleton A, Giallauria F, Metter J, de Boer IH, Haritunians T, Lumley T, Siscovick D, Psaty BM, Zillikens MC, Oostra BA, Feitosa M, Province M, de Andrade M, Turner ST, Schillert A, Ziegler A, Wild PS, Schnabel RB, Wilde S, Munzel TF, Leak TS, Illig T, Klopp N, Meisinger C, Wichmann HE, Koenig W, Zgaga L, Zemunik T, Kolcic I, Minelli C, Hu FB, Johansson A, Igl W, Zaboli G, Wild SH, Wright AF, Campbell H, Ellinghaus D, Schreiber S, Aulchenko YS, Felix JF, Rivadeneira F, Uitterlinden AG, Hofman A, Imboden M, Nitsch D, Brandstatter A, Kollerits B, Kedenko L, Magi R, Stumvoll M, Kovacs P, Boban M, Campbell S, Endlich K, Volzke H, Kroemer HK, Nauck M, Volker U, Polasek O, Vitart V, Badola S, Parker AN, Ridker PM, Kardia SL, Blankenberg S, Liu Y, Curhan GC, Franke A, Rochat T, Paulweber B, Prokopenko I, Wang W, Gudnason V, Shuldiner AR, Coresh J, Schmidt R, Ferrucci L, Shlipak MG, van Duijn CM, Borecki I, Krämer BK, Rudan I, Gyllensten U, Wilson JF, Witteman JC, Pramstaller PP, Rettig R, Hastie N, Chasman DI, Kao WH, Heid IM, Fox CS. New loci associated with kidney function and chronic kidney disease. Nat Genet 42: 376-384, 2010.
27. Kreisberg JI, Karnovsky MJ. Focal glomerular sclerosis in the fawnhooded rat. Am J Pathol 92: 637-652, 1978.
28. Kugita M, Nishii K, Morita M, Yoshihara D, Kowa-Sugiyama H, Yamada K, Yamaguchi T, Wallace DP, Calvet JP, Kurahashi H, Nagao S. Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling. Am J Physiol Renal Physiol 300: F177-F188, 2011.
29. Kuijpers MHM, Provoost AP, de Jong W. Development of Hypertension and Proteinuria with age in Fawn-Hooded Rats. Clin Exp Pharmacol Physiol 13: 201-209, 1986.
30. Lager DJ, Qian Q, Bengal RJ, Ishibashi M, Torres VE. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease. Kidney Int 59: 126-136, 2001.
31. Loghman-Adham M, Soto CE, Inagami T, Sotelo-Avila C. Expression of components of the renin-angiotensin system in autosomal recessive polycystic kidney disease. J Histochem Cytochem 53: 979-988, 2005.
32. Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhuisen B, Saris JJ, Reynolds DM, Cai Y, Gabow PA, Pierides A, Kimberling WJ, Breuning MH, Deltas CC, Peters DJM, Somlo S. PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science 272: 1339-1342, 1996.
33. Moreno C, Kennedy K, Andrae JW, Jacob HJ. Genome-wide scanning with SSLPs in the rat. Methods Mol Med 108: 131-138, 2005.
34. Moyer JH, Lee-Tischler MJ, Kwon HY, Schrick JJ, Avner ED, Sweeney WE, Godfrey VL, Cacheiro NL, Wilkinson JE, Woychik RP. Candidate gene associated with a mutation causing recessive polycystic kidney disease in mice. Science 264: 1329-1333, 1994.
35. Mrug M, Li R, Cui X, Schoeb TR, Churchill GA, Guay-Woodford LM. Kinesin family member 12 is a candidate polycystic kidney disease modifier in the cpk mouse. J Am Soc Nephrol 16: 905-916, 2005.
36. Mrug M, Zhou J, Woo Y, Cui X, Szalai AJ, Novak J, Churchill GA, Guay-Woodford LM. Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int 73: 63-76, 2007.
37. Nauta J, Goedbloed MA, Herck HV, Hesselink DA, Visser PIM, Willemsen ROB, Dokkum RPEV, Wright CJ, Guay-Woodford LM. New rat model that phenotypically resembles autosomal recessive polycystic kidney disease. J Am Soc Nephrol 11: 2272-2284, 2000.
38. Nauta J, Ozawa Y, Sweeney WE, Rutledge JC, Avner ED. Renal and biliary abnormalities in a new murine model of autosomal recessive polycystic kidney disease. Pediatr Nephrol 7: 163-172, 1993.
39. Nemo R, Murcia N, Dell KM. Transforming growth factor alpha (TGF-[alpha]) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease. Pediatr Res 57: 732-737, 2005.
40. Onuchic LF, Furu L, Nagasawa Y, Hou X, Eggermann T, Ren Z, Bergmann C, Senderek J, Esquivel E, Zeltner R, Rudnik-Schöneborn S, Mrug M, Sweeney W, Avner ED, Zerres K, Guay-Woodford LM, Somlo S, Germino GG. PKHD1, the polycystic kidney and hepatic disease 1 gene, encodes a novel large protein containing multiple immunoglobulin-like plexin-transcription-factor domains and parallel beta-helix 1 repeats. Am J Hum Genet 70: 1305-1317, 2002.
41. Rossetti S, Harris PC. Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease. J Am Soc Nephrol 18: 1374-1380, 2007.
42. Roy S, Dillon MJ, Trompeter RS, Barratt TM. Autosomal recessive polycystic kidney disease: long-term outcome of neonatal survivors. Pediatr Nephrol 11: 302-306, 1997.
43. Saburi S, Hester I, Fischer E, Pontoglio M, Eremina V, Gessler M, Quaggin SE, Harrison R, Mount R, McNeill H. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease. Nat Genet 40: 1010-1015, 2008.
44. Schieren G, Rumberger B, Klein M, Kreutz C, Wilpert J, Geyer M, Faller D, Timmer J, Quack I, Rump LC, Walz G, Donauer J. Gene profiling of polycystic kidneys. Nephrol Dialysis Transplant 21: 1816-1824, 2006.
45. Skouloudaki K, Puetz M, Simons M, Courbard JR, Boehlke C, Hartleben BR, Engel C, Moeller MJ, Englert C, Bollig F, Schäfer T, Ramachandran H, Mlodzik M, Huber TB, Kuehn EW, Kim E, Kramer-Zucker A, Walz G. Scribble participates in Hippo signaling and is required for normal zebrafish pronephros development. Proc Natl Acad Sci USA 106: 8579-8584, 2009.
46. Song X, Di Giovanni V, He N, Wang K, Ingram A, Rosenblum ND, Pei Y. Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks. Hum Mol Genet 18: 2328-2343, 2009.
47. Sweeney W, Avner E. Molecular and cellular pathophysiology of autosomal recessive polycystic kidney disease (ARPKD). Cell Tiss Res 326: 671-685, 2006.
48. Upadhya P, Churchill G, Birkenmeier EH, Barker JE, Frankel WN. Genetic modifiers of polycystic kidney disease in intersubspecific KAT2J mutants. Genomics 58: 129-137, 1999.
49. Weatherall DJ. Phenotype- genotype relationships in monogenic disease: lessons from the thalassaemias. Nat Rev Genet 2: 245-255, 2001.
50. Zerres K, Mücher G, Becker J, Steinkamm C, Rudnik-Schöneborn S, Heikkilä P, Rapola J, Salonen R, Germino GG, Onuchic L, Somlo S, Avner ED, Harman LA, Stockwin JM, Guay-Woodford LM. Prenatal diagnosis of autosomal recessive polycystic kidney disease (ARPKD): molecular genetics, clinical experience, and fetal morphology. Am J Med Genet 76: 137-144, 1998.